Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oncolytic adenovirus with enhanced replication properties comprising modifications in E1A, E3, and E4

Oncolytic adenovirus with enhanced replication properties comprising modifications in E1A, E3, and E4

US Patent 12365878 · Granted Jul 22, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alphavirus-based replicons for administration of biotherapeutics2025
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2025
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2025
Compositions and methods for expression of IL-12 and IL-1RA2024
Tumor-targeting synthetic adenoviruses and uses thereof2023
Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound2023
Compositions and methods for the prevention and treatment of rabies virus infect2023
Compositions and methods for inducing ESR1, PI3K, HER2, and HER3 immune response2022
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2022
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2022
High throughput assay for measuring adenovirus replication kinetics2021
High throughput assay for measuring adenovirus replication kinetics2021